48th Union World Conference on Lung Health

October 11, 2017 - 12:15am - October 14, 2017 - 8:00pm
Venue: 
Expo Guadalajara,Guadalajara, Mexico

Join us at the 48th Union World Conference on Lung Health in Guadalajara, Mexico, October 11-14. MSH staff from seven countries will be participating in a variety of symposia, workshops, posters, and oral presentations to share our experience and expertise on a range of topics that include drug procurement and safety; QuanTB, an electronic system designed to improve procurement processes, ordering, and supply planning for TB treatment; Urban DOTS implementation; MDR-TB program implementation; GeneXpert scale-up; contact investigation; the integration of TB and diabetes screening and treatment in Ethiopia and Afghanistan; the integration of TB testing networks; biosafety, and more.

 

WEDNESDAY, OCTOBER 11

Workshop – Programmatic implementation of bedaquiline and delamanid: experiences in drug procurement, technical assistance, clinical management and drug safety monitoring

Wednesday, October 11 | 11:30 – 17:30 | Hall 8 – Events Ballroom

The purpose of this session will be to share lessons learned from countries that have expanded bedaquiline (BDQ) and delamanid (DLM) through the GDF and have used that experience to strengthen pharmacovigilance in order to achieve better TB treatment outcomes. As countries introduce and scale up shorter treatment regimen (STR), the use of BDQ, DLM and companion medicines will be critical for those ineligible for STR. 

  • First, let us get the numbers: order status and patients enrolled on bedaquiline and delamanid (Andre Zagorski, Switzerland, SIAPS)
  • Translating World Health Organization (WHO) Active TB Drug Safety Monitoring and Management (aDSM) at country level: data management and causality analysis (Nino Lomtadze, Georgia, SIAPS)
  • Technical assistance to build national TB programme capacity for active pharmacovigilance for TB new drugs and shortened regimen: a system approach in five countries (Dumebi Mordi, United States of America, SIAPS)

Workshop – Quantification challenges in times of new TB medicines and regimen: country experiences and speed-course using a digital tool

Wednesday, October 11 | 14:30 – 17:30 | Minerva II

Coordinator: Niranjan Konduri, United States of America

This workshop consists of a plenary part with presentations and a ‘speed-course’ on the QuanTB tool with practical exercises. During the ‘speed-course’, participants will have the opportunity to use QuanTB with hands-on practical exercises. At the end of the workshop, participants will be able to identify key data for quantification, quantify first and second-line medicines and review quantification outputs. Participants will develop transition plans for introduction of new tools in different scenarios and implement an EWS suitable for their context.

  • A new e-learning methodology to meet the demand for quantification and forecasting, (Kanjinga Kakanda, United States of America, SIAPS)
  • Applying the Pharmaceutical Systems Strengthening (PSS) approach in improving quantification and early warning systems for TB commodities (Wonder Goredema, United States of America, SIAPS)

THURSDAY, OCTOBER 12 

ORAL PRESENTATIONS

Short Oral Abstract Session | 10:30-12:00 | Hall 11 – Jalisco Hall

Improving care and support for patients

  • SOA-311-12 - Evaluating the effectiveness of tuberculosis care providers on treatment outcomes in Afghanistan: a cross-sectional study, GQ Qader, SM Sayedi, MN Samadi, MK Ayubi, MH Akhgar, AB Maseed, NA Zahid, Afghanistan, Challenge TB (10:30-10:36)
  • SOA-312-12 - Exploring tuberculosis services provision and patient satisfaction in Afghanistan, M Shefa, N Ahmadzada, M Sarwari, A Hamim, T Noori, H Habib, B Ahmad, MN Samadi, Afghanistan, Challenge TB (10:36-10:42)
  • SOA-315-12 - Efficacy of DOTS implementation in densely populated cities of Afghanistan: experience from Jalalabad city, GQ Qader, F Bakhtani, L Faqiri, A Hamim1, AB Maseed, SM Sayedi, N Ahmadzada, MK Rashidi, Afghanistan, Challenge TB (10:54-11:00)
  • SOA-319-12 - Treatment outcome patterns among tuberculosis patients exclusively treated at health facility level versus community/health post level in Ethiopia, E Getachew, N Hiruy, D Jerene, D Habte2, S Tsegaye, D Assefa, Y Kassie, P Suarez, Challenge TB (11:18-11:24)

Oral Abstract Session | 10:30-12:00 | Hall 8 – Events Ballroom

Access to patient care: is it their right, privilege or ethical challenge?

  • OA-111-12 - Role of ex-tuberculosis patient engagement in TB care and control in Afghanistan: data review, B Ahmad, M Shefa, N Ahmadzada, G Qader, MN Samadi, M Melese, M Kamin, Challenge TB (10:54-11:00)
  • OA-114-12 - Exploring the effectiveness of community engagement in tuberculosis treatment outcomes in Afghanistan: a cohort analysis, M Shefa, B Ahmad, MN Samadi, N Ahmadzada, T Noori, M Sarwari, M Melese, P Suarez, Challenge TB (11:16-11:26)

Oral Abstract Session | 10:30-12:00 | Hall 14 – Jalisco Hall

Recent developments in TB co-morbidities: updates from the front line

  • OA-127-12 - Effectiveness of screening drug addicts for pulmonary tuberculosis in Afghanistan: a cross-sectional study, GQ Qader, MK Rashidi, A Hamim, M Shefa, SM Sayedi, MK Seddiq, N Ahmadzada, PG Suarez, Challenge TB, (11:10-11:20) 

POSTER PRESENTATION | 12:15 – 13:15 | POSTER AREA

BACK TO BASICS: DIAGNOSIS, NOTIFICATION AND OUTBREAK INVESTIGATION

PD-515-12 - Seasonal pattern of tuberculosis case notification in Afghanistan, 2005—2016, Mohammad Nazim Samadi, Afghanistan, Challenge TB

MUDDYING THE WATERS: CO-MORBIDITIES IN DRUG RESISTANT TB

PD-539-12 - Mortality predictors among drug-resistant tuberculosis patients in Uganda, Samuel Kasozi, Uganda, TRACK TB 

WHERE ARE THEY? CASE FINDING AND PREVENTIVE THERAPY FOR PEDIATRIC TB

PD-585-12 - Improvements in IPT uptake rates in under-five children in Ethiopia: results of a five-year program, Dereje Habte, Ethiopia, Challenge TB

ORAL PRESENTATIONS

Short Oral Abstract Session| 14:00–15:30 | Hall 9 – Jalisco Hall

Risks and reasons for modifying approaches

  • SOA-341-12 - Seasonality in tuberculosis case notification rate and its implications for developing season-based case finding strategies in Ethiopia, Z Gashu, D Jerene, D Bekele, G Alem, N Hiruy, D Habte, Y Kebede Haile, P Suarez, Challenge TB (15:00-15:06) 

Short Oral Abstract Session| 14:00–15:30 | Hall 12 – Jalisco Hall

TB in correctional facilities: an update on detection and care

  • SOA-349-12 - Effectiveness of active case finding in addressing tuberculosis control in prisons, A Hamim, SM Sayedi, GQ Qader, L Manzoor, N Ahmadzada, H Faqiryar, MK Rashidi, PG Suarez, Afghanistan, Challenge TB (14:42 – 14:48) 

Symposium – TB and diabetes mellitus in high-burden settings: implementation and research experiences from Asian, African, Caribbean and Latin American countries

Thursday, October 12 | 16:00-17:30 | Hall 6 – Events Ballroom

Chair: Pedro Guillermo Suarez, United States of America

We now have strong evidence and programmatic experience that demonstrate the feasibility and high yield of bi-directional screening for TB and diabetes mellitus (DM). However more data is needed on larger scale implementation experiences in real-life situations and in settings with diverse backgrounds. Our specific objectives are to: 

  1. Review global updates on the implementation of TB/DM integration. 
  2. Share innovations and implementation experiences from different regions of the world.
  • Innovative models for TB/diabetes integration: a successful example from Ethiopia, Degu Jerene, Ethiopia, Challenge TB (16:20-16:40)
  • Exploring the magnitude of TB among patients with diabetes mellitus in Afghanistan, Qader Ghulam, Afghanistan, Challenge TB (17:00-17:20)

Short Oral Abstract Session| 16:00–17:30 | Hall 9 – Jalisco Hall

Identifying factors to reach 90-90-90 goals

  • OA-374-12 - Tuberculosis patients from outside Kampala city carry a higher risk of unfavorable treatment outcomes, R Kaliisa, A Burua, D Kimuli, E Birabwa, C Nanziri, D Okello, D Lukoye, P Suarez, Uganda, TRACK TB (16:00-16:06)
  • SOA-381-12 - Exploring quality of tuberculosis surveillance data in Afghanistan: a cross-sectional study, GQ Qader, AB Maseed, MK Rashidi, MK Seddiq, H Manochehr, SH Danish, N Ahmadzada, Challenge TB (16:42 – 16:48)

Short Oral Abstract Session| 16:00–17:30 | Hall 13 – Jalisco Hall

Leave no one behind – the hard work of finding cases

  • SOA-386-12 - Impact of community health worker household TB screening on case notification in Afghanistan: a data review, MN Samadi, M Shefa, BA Maseed, GQ Qader, MK Rashidi, N Ahmadzada, M Melese, PG Suarez, Challenge TB (16:12 – 16:18)
  • SOA-392-12 - Gaps in TB screening at health facilities have contributed to decline in TB case notification in Kampala city, D Lukoye, S Ntudhu, R Mpirirwe, R Byaruhanga, A Burua, S Dejene, D Sama, P Suarez, Uganda, TRACK TB (16:48 – 16:54)

FRIDAY, OCTOBER 13, 2017

ORAL PRESENTATIONS

Short Oral Abstract Session| 10:30 – 12:00 | Hall 8 – Events Ballroom

HIV and TB lessons from Africa

  • SOA-398-13 - High HIV prevalence among presumptive tuberculosis patients in an urban setting: lessons from Kampala city, Uganda, D Lukoye, R Byaruhanga, N Kirirabwa, S Kasozi, S Zalwango, S Dejene, S Ntudhu, P Suarez, TRACK TB (10:54-11:00)

Oral Abstract Session | 10:30-12:00 | Hall 3 – Events Ballroom

Active TB case finding and retrieving missing cases: engagement of community volunteers, civil society, pharmacists and other stakeholders

  • OA-146-13 - Interventions led to improved contribution of community tuberculosis care to tuberculosis case notification in two regions of Ethiopia, E Getachew, D Bekele, N Gebrie, K Melkieneh, Z Gashu, S Negash, D Jerene, P Suarez, Challenge TB (10:40-10:50)

POSTER PRESENTATION | 12:45 – 13:45 | POSTER AREA 

USING TECHNOLOGY TO ADVANCE DRUG-RESISTANT TB CARE

PD-693-13 - Electronic reporting of adverse effects of second-line anti-tuberculosis drugs in Nigeria, Opeyemi Emmanuel, Nigeria, Challenge TB

PD-694-13 - Effectiveness of mHealth technologies in the management of DR-TB DOTS at community level in Bangladesh, Sayeed Imtiaz, Bangladesh, Challenge TB

PRIVATE SECTOR ENGAGEMENT IN TB CARE: LESSONS LEARNED FROM LOW-INCOME COUNTRIES

PD-731-13 - Private sector effectiveness in treating TB patients: a document review of the Kabul urban DOTS experience, Said Mirza Sayedi, Afghanistan, Challenge TB

PD-735-13 - Effects of engaging public and private health facilities in TB case finding in Afghanistan: urban DOTS implementation experiences, Azizullah Hamim, Afghanistan, Challenge TB

PD-740-13 - Outcomes of engaging a gynecological hospital in TB case notification and fertility status of women in Kabul city, Afghanistan, Ehsanullah Darwish, Afghanistan, Challenge TB

TB ACROSS KEY POPULATIONS
PD-749-13 - TB case notification rates among various key population groups in Ethiopia, Nebiyu Hiruy, Ethiopia, Challenge TB

MAKING VIRTUAL A REALITY: MHEALTH SOLUTIONS TO TB CARE

PD-793-13 - Mobile technology use improves tuberculosis treatment outcomes in Kabul city, Said Mirza Sayedi, Afghanistan, Challenge TB

WHAT YOU SEE IS WHAT YOU GET: UNDERSTANDING TB IN CHILDREN

PD-803-13 - Under-diagnosis of drug-resistant childhood TB compared to drug susceptible counterparts in three large regions of Ethiopia, Nebiyu Hiruy, Ethiopia, Challenge TB

PD-808-13 - Role of two pediatric hospitals in tuberculosis case detection and treatment in Kabul, Afghanistan, Habibuddin Faqiryar, Afghanistan, Challenge TB

DOUBLE TROUBLE: THE IMPACT OF DIABETES AND TB

PD-812-13 - Limitations and challenges of implementing tuberculosis screening in diabetes mellitus care in Bangladesh, Zakia Sultana Siddique, Bangladesh, Challenge TB

PD-814-13 - Outcomes of screening diabetic patients for tuberculosis in Afghanistan, 2016: a cross-sectional study, Ghulam Qader, Afghanistan, Challenge TB 

XPERT IMPLEMENTATION: REALITIES IN THE FIELD

PD-829-13 - Chronic GeneXpert maintenance challenges in Bangladesh, Sarder Tanzir Hossain, Bangladesh, Challenge TB

PD-835-13 - Internet access is the main deterrent to online reporting of GeneXpert data in Kampala, Denis Joel Sama, Uganda, TRACK TB

SOLUTION TO LABORATORY IMPLEMENTATION CHALLENGES

PD-836-13 - Improved utilization of Xpert® MTB/RIF technology for TB diagnosis in Kampala, Byaruhanga Raymond, Uganda, TRACK TB

PD-842-13 - Comparison of randomized blinded rechecking for fluorescence light-emitting diode and Ziehl-Neelson microscopy in three regions of Ethiopia, Gonfa Ayana, Ethiopia, Challenge TB

SEARCHING HIGH SEARCHING LOW: CASE FINDING STRATEGIES

PD-845-13 - Outcome of intensified case finding for tuberculosis case detection in Munuki and Kator primary health care centers, Berhane Assefa, Ethiopia, Challenge TB 

Symposium – Building and strengthening specimen transport and referral systems for TB testing networks: Solutions through integration and innovation 

Friday, October 13 | 14:00-15:30 | Hall 12 – Jalisco Hall

Chair: Alaine Umubyeyi Nyaruhirira, South Africa, PHT

Given that the tools for highly sensitive TB detection and comprehensive drug susceptibility testing (DST) do not yet exist at point-of-care (POC), an efficient specimen transport and referral network is critical in reaching the goals of increased TB case detection and universal DST as described in the End TB Strategy and Global Plan to End TB. In this symposium we will share current guidance and success stories in building efficient specimen transport and referral systems in integrated networks and using recent innovations, including alternative means of transport and use of sample transport media.

  • Strengthening specimen transport and referral systems: the Global Laboratory Initiative perspective, Alaine Umubyeyi Nyaruhirira, South Africa, PHT (14:00-14:15) 

ORAL PRESENTATIONS

Short Oral Abstract Session| 14:00–15:30 | Hall 13 – Jalisco Hall

MDR-TB: Predictors of treatment outcomes

  • SOA-414-13 - Factors associated with unfavorable treatment outcomes among multi-drug resistant tuberculosis patients treated at a tertiary hospital in Tigray Region, Northern Ethiopia, F Desalegn, E Michael, M Abraha, M Tsehaye, A Gebremedhin, N Thaimanot, E Haregot, D Jerene, Challenge TB (14:00-14:06)
  • SOA-416-13 - Community-based MDR-TB diagnosis and management in Bangladesh, K Jahan, P Daru, R Haq, M Melese, V Begum, M Khan, Bangladesh, Challenge TB (14:18-14:26) 
  • SOA-417-13 - Contribution of private health facilities to the management of MDR-TB: experiences from Kampala, Uganda, E Kizito, S Kasozi, N Kirorabwa, R Byaruhanga, D Birabwa, S Turyahabwe, S Dejene, P Suarez, TRACK TB

Oral Abstract Session| 14:00–15:30 | Hall 11 – Jalisco Hall

Stopping TB transmission: infection control in congregate settings

  • OA-170-13 - FAST strategy to prevent TB and diabetes co-morbidity and prevent TB transmission in congregate settings, K Jahan, P Daru, R Haq, D Hossain, M Melese, M-U Alam, Bangladesh, Challenge TB (14:20-14:30)

Oral Abstract Session| 16:00–17:30 | Hall 13 – Jalisco Hall

MDR-TB: treatment outcomes using new drugs

  • OA-194-13 - Drug resistant TB burden among contacts of drug resistant TB patients: results from routine program implementation in three regions of Ethiopia, N Hiruy, B Ayele, Y Molla, D Habte, T Setargie, G Gizatie, D Jerene, M Melese, Challenge TB (17:00-17:10)

Meeting – CTB meeting on the introduction of ND&STR (closed meeting)

Friday, October 13 | 16:45 – 17:45 | The Westin Guadalajara, Av de Las Rosas 2911, Guadalajara | Rosedal Room

SATURDAY, OCTOBER 14, 2017 

ORAL PRESENTATIONS

Short Oral Abstract Session| 10:30 – 12:00 | Hall 4 – Events Ballroom

Who pays, how much, and to what end?

  • SOA-441-14 - Pre and post-diagnosis costs of tuberculosis to patients on DOTS in districts of Southwest Ethiopia: a longitudinal study, A Asres, D Jerene, W Deressa, Mizan Tepi University, Public Health, Mizan Aman, Ethiopia, Challenge TB (11:06-11:12) 

Oral Abstract Session | 10:30-12:00 | Hall 12 – Jalisco Hall

Training Healthcare Workers

  • OA-212-14 - Blended learning for capacity building of health care workers in TB-HIV: results of a comparative study in Ethiopia, T Anteneh, D Habte, N Hiruy, M Gebre, Y Kassie, A Aklilu, D Jerene, P Suarez, Challenge TB (11:10-11:20)

Symposium – Implementing and sustaining the appropriate biosafety in TB laboratories: ZN smears through DST cultures

Saturday, October 14 | 10:30-12:00 | Hall 8 – Events ballroom

Chair: Alaine Umubyeyi Nyaruhirira, South Africa, PHT

Despite significant investments in infrastructure upgrades, particularly at reference laboratory levels, many countries still have unsafe working environments (microscopy/GeneXpert to culture and DST). Adequate operation and maintenance of biosafety equipment (BSCs, centrifuges, HVAC systems) and provision of personal protective equipment (PPE) such as respirators, gloves, etc is lacking. Best practices are essential, yet they are not well understood. Administrative, environmental and PPE must be in place to ensure worker safety and quality diagnostic results. This session will highlight effective approaches to solving issues faced by laboratories and demonstrate synergy of biosafety with infection control in the process of achieving quality and accreditation.

POSTER PRESENTATION | 12:45 – 13:45 | POSTER AREA

DETECT, REPORT AND TREAT: AN ECHO FROM SURINAME TO SOUTH AFRICA

PD-873-14 - Experiences and perspectives on extra pulmonary tuberculosis in 15 provinces of Afghanistan, 2015 – 2016, Said Mirza Sayedi, Afghanistan, Challenge TB

KNOCK KNOCK? WHO IS THERE? HOUSEHOLD AND CONTACT CASE FINDING. KNOW, SHARE, ACT!

PD-907-14 - Clinical, programmatic and epidemiological significance of wide-scale implementation of tuberculosis contact investigation in Ethiopia, Degu Jerene, Ethiopia, Challenge TB

DIAGNOSIS AND TREATMENT: UPDATES ON PEDIATRIC TB

PD-923-14 - Comparable yield of TB in children and adults among presumptive tuberculosis patients who underwent Xpert testing in Ethiopia, Nebiyu Hiruy, Ethiopia, Challenge TB

VULNERABLE POPULATIONS, HOMELESS TO MIGRANTS

PD-984-14 - Expanding TB diagnosis and community-based tuberculosis management: addressing vulnerable ethnic populations and tea garden workers in Bangladesh, Mohammad Shahrear Farid, Bangladesh

PD-985-14 - Contribution of active contact screening to TB case detection in Urban DOTS supported provinces in Afghanistan, Azizullah Hamim, Afghanistan, Challenge TB

EXPERT USE OF XPERT: DEVELOPING THE EVIDENCE BASE

PD-991-14 - Category-wise burden of DR-TB diagnosed through Xpert® MTB/RIF: experience from Bangladesh, Sarder Tanzir Hossain, Bangladesh, Challenge TB

PD-998-14 - Sensitization for clinicians followed by weekly service monitoring contributes to improved uptake of Xpert in Tigray Region, Ethiopia, Challenge TB

INFECTION CONTROL: ENDING TRANSMISSION

PD-1007-14 - Outcomes of tuberculosis infection control measures in public health facilities in Afghanistan: a document review, Ghulam Qader, Afghanistan, Challenge TB

ORAL PRESENTATIONS

Short Oral Abstract Session| 14:00 – 15:30 | Hall 6 – Events Ballroom

TB laboratory services:  lessons from the field

Chair: Alaine Umubyeyi Nyaruhirira, South Africa

  • SOA-452-14 - Attaining universal access to DST for tuberculosis patients in Uganda: experience from Kampala city on optimal utilisation of Xpert® MTB/RIF, A Burua, S Kasozi, S Turyahabwe, E Birabwa, D Lukoye, R Byaruhanga, P Suarez, Uganda, TRACK TB (14:00-14:06)
  • SOA-459-14 - Cold chain vehicle specimen transportation system for TB culture improved quality of laboratory service in Ethiopia, G Tibesso, G Ayana, M Melese, D Habte, N Hiruy, S Tsegaye, D Jerene, P Suarez (14:42-14:48)

Short Oral Abstract Session| 14:00 – 15:30 | Hall 11 – Jalisco Hall

Thinking holistically – many contributors to improving TB treatment outcomes

  • SOA-479-14 - Comparative analysis of the ethambutol (EH) - rifampicin (RH) switch on treatment outcomes of tuberculosis patients in Mulago National Referral Hospital, D Kimuli, D Lukoye, DJ Sama, NS Kirirabwa, S Adakun, E Birabwa, S Pedro, R Byaruhanga, Uganda, TRACK TB
Printer Friendly VersionPDF